May 5, 2011 – At the 2011 European Society for Therapeutic Radiology and Oncology (ESTRO) exhibition at the ExCel Centre in London, Elekta will demonstrate advanced solutions that provide clinicians with the tools to save and improve lives of cancer patients worldwide. This includes Elekta's new RFID system, Identify, which is designed to increase staff confidence in the integrity of patient identification and set up.

Identify harnesses precision radiofrequency identification technology and will ensure the right patient is being treated at the right location and with the correct set up and equipment. Identify will feature complete integration with Elekta's Mosaiq Oncology Information System, enabling patient queuing, selection of patient details in monitoring of set-up position, optimizing workflow and enhancing safety. Identify will be a scalable solution – from the treatment room to the entire department – allowing centers to grow as needs change.

Throughout the five major solution areas at the Elekta booth, the company will demonstrate how its digital platforms offer robust upgrade paths to accommodate a wide range of clinical requirements. The solution areas are:
Secure Workflow – personalized efficiency
Stereotaxy – premium solutions for the most challenging cases
Delivery – clinically focused, digitally controlled
Imaging – inspiring clinical confidence
Quality Assurance – completing the picture

In addition, Elekta will host a lunch symposium titled Throughput with Confidence on Monday, May 9 at the Capital Suites. The symposium will feature presentations by notable experts in the field of radiation oncology:
Professor Frank Lohr, University Hospital, Mannheim, Germany: Efficient VMAT Planning and Delivery
Ben J. Mijnheer, Ph.D., NKI/AvL, Amsterdam, Netherlands: Experiences from AvL with EPID-based In-Vivo Dosimetry
PD Reinhart A. Sweeney, University Hospital, Wurzburg, Germany; Christian Hieronimi, Elekta: Identify - who, what, where and how. Now!

For more information: www.elekta.com


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
News | Oncology Information Management Systems (OIMS)

May 30, 2024 — RaySearch Laboratories AB announced the release of the latest version of RayCare, the next generation ...

Time May 30, 2024
arrow
Subscribe Now